ストックスクリーナーアプリを入手
0.2706
6.04%
-0.0174
アフターアワーズ：
.27
-0.0006
-0.22%
Oragenics Inc (OGEN) 最新ニュース
OGEN Stock Plummets to 52-Week Low at $0.28 Amid Steep Decline - Investing.com Australia
Oragenics: Q3 Earnings Snapshot - The Pioneer
StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN) - Defense World
SEC Form DEF 14A filed by Oragenics Inc. - Quantisnow
OGEN stock plunges to 52-week low, touches $0.28 By Investing.com - Investing.com Australia
500: Something went wrong - Investing.com India
OGEN stock plunges to 52-week low, touches $0.28 - Investing.com
Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World
Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury
Oragenics, Inc. to Present at the Centurion One Capital 2nd Annual Bahamas Summit - Marketscreener.com
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit - GlobeNewswire
Fancamp Announces Airborne EM-MAG-RADIOMETRIC Survey at New Brunswick Acadian Gold Joint Venture with Lode Gold - The Manila Times
Check Out Oragenics Inc (OGEN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Oragenics Shares Investor Presentation Online - TipRanks
Oragenics inks sales agreement for at-the-market stock offering - Investing.com
Oragenics inks sales agreement for at-the-market stock offering By Investing.com - Investing.com South Africa
Oragenics Inc (OGEN) stock analysis: A comprehensive overview - US Post News
The Future of Oragenics Inc: Analyzing OGEN - The InvestChronicle
Oragenics advances concussion treatment with ONP-002 By Investing.com - Investing.com South Africa
Oragenics advances concussion treatment with ONP-002 - Investing.com India
Metric Deep Dive: Understanding Oragenics Inc (OGEN) Through its Ratios - The Dwinnex
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation - GlobeNewswire
OGEN stock touches 52-week low at $0.37 amid sharp annual decline - Investing.com India
OGEN’s valuation metrics: A comprehensive analysis - US Post News
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002 - The Manila Times
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate - Yahoo Finance
Naples Soap Company Announces Reverse Stock Split - Business Wire
CDE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Coeur Mining, Inc. Is Fair to Shareholders - Business Wire
Ferguson Files Form 8-K and Prospectus Supplement to its Shelf Registration Statement - Business Wire
Photo of Genesco Employees Fitting Students with New Shoes at Ida B. Wells Elementary School in Nashville Available on Business Wire's Website and the Associated Press Photo Network - Business Wire
Webcast Alert: Olympic Steel to Announce Third-Quarter 2024 Financial Results After Market Closes on October 31, 2024 - Business Wire
Reinsurance Group of America Announces Third Quarter Earnings Release Date, Webcast - Business Wire
Graco Inc. Announces Third Quarter 2024 Earnings Conference Call - Business Wire
Momentive Technologies Acquires Spherical Alumina and Spherical Silica Businesses From Sibelco - Business Wire
Wellfit Technologies to Share Expert Insights on AADOM Radio: Demystifying Dental Financing for Profitability - Business Wire
OGEN stock touches 52-week low at $0.38 amid sharp annual decline By Investing.com - Investing.com South Africa
OGEN stock touches 52-week low at $0.38 amid sharp annual decline - Investing.com
Toyoda Gosei Invests in TriOrb Inc., a Startup Developing Mobile Robots With Omnidirectional Movement Capability - Business Wire
LLAP Investors Have Opportunity to Lead Terran Orbital Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Oragenics (AMEX:OGEN) Stock Quotes, Forecast and News Summary - Benzinga
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event - Business Wire
Expliseat Unveils an Ultra-Light Train Seat at Innotrans - Business Wire
OGEN stock touches 52-week low at $0.47 amid sharp annual decline - Investing.com India
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):